Can pre-therapy 68Ga-PSMA-11 PET SUVs predict absorbed doses across multiple cycles of 177Lu-PSMA-617 therapy of mCRPC patients?

被引：0
|
作者：
Brosch-Lenz, J. [1 ]
Colpo, N. [2 ]
Bloise, I. [1 ]
Hou, X. [1 ]
Parulekar, W. R. [3 ]
Dellar, C. [3 ]
Saad, F. [4 ]
Chi, K. [2 ]
Wilson, D. [2 ]
Benard, F. [2 ]
Rahmim, A. [1 ]
Uribe, C. [2 ]
机构：
[1] BC Canc, Res Inst, Vancouver, BC, Canada
[2] BC Canc, Vancouver, BC, Canada
[3] Queens Univ Kingston, Canadian Canc Trials Grp, Kingston, ON, Canada
[4] CRCHUM, Inst Canc Montreal, Prostate Canc Res, Montreal, PQ, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-715
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [21] The effect of tumor burden in 68GA-PSMA-PET/CT on tracer uptake into kidneys in 68Ga-PSMA-PET/CT and the absorbed dose per administered GBq 177Lu-PSMA-617 during a following therapy
    Wichert, J.
    Happel, C.
    Kranert, W. T.
    Groener, D.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Mader, N.
    Banek, S.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S423 - S424
  • [22] Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC A Proof-of-Principle Application
    Bal, Chandrasekhar
    Yadav, Madhav Prasad
    Ballal, Sanjana
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : E386 - E387
  • [23] Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy
    Santo, Giulia
    Di Santo, Gianpaolo
    Zelger, Bettina
    Virgolini, Irene
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (03): : 224 - 226
  • [24] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Heinzel, Alexander
    Boghos, Dima
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1054 - 1062
  • [25] Investigation of [177Lu]Lu-PSMA-617 therapy minimum cycle interval with [68Ga]Ga-PSMA-11 PET/CT
    Costa, G.
    Yousefzadeh-Nowshahr, E.
    Orlov, C.
    Fitzpatrick, K.
    Frey, K.
    Beer, A.
    Dewaraja, Y.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S210 - S210
  • [26] [68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment
    Peters, Steffie M. B.
    Hofferber, Regina
    Prive, Bastiaan M.
    de Bakker, Maarten
    Gotthardt, Martin
    Janssen, Marcel
    de Lange, Frank
    Muselaers, Constantijn H. J.
    Mehra, Niven
    Witjes, J. Alfred
    Costa, Pedro F.
    Nagarajah, James
    Konijnenberg, Mark W.
    Jentzen, Walter
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (04) : 1101 - 1112
  • [27] [68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment
    Steffie M. B. Peters
    Regina Hofferber
    Bastiaan M. Privé
    Maarten de Bakker
    Martin Gotthardt
    Marcel Janssen
    Frank de Lange
    Constantijn H. J. Muselaers
    Niven Mehra
    J. Alfred Witjes
    Pedro F. Costa
    James Nagarajah
    Mark W. Konijnenberg
    Walter Jentzen
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1101 - 1112
  • [28] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Alexander Heinzel
    Dima Boghos
    Felix M. Mottaghy
    Florian Gaertner
    Markus Essler
    Dirk von Mallek
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1054 - 1062
  • [29] Dosimetry of three consecutive cycles of 177Lu-PSMA-617 therapy in patients with advanced prostate cancer
    Rahbar, Kambiz
    Surmann, Anne-Marie
    Razlaw, Natalia
    Braeuer, Axel
    Boegemann, Martin
    Schafers, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [30] Can a cutoff be set for pre-treatment 68Ga-PSMA-11 PET/CT parameters to predict 177Lu-PSMA-I&T response and patient survival?
    Mirshahvalad, S.
    Eisazadeh, R.
    Rendl, G.
    Gampenrieder, S.
    Schweighofer-Zwink, G.
    Griessner, H.
    Pirich, C.
    Beheshti, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S651 - S651
12345